Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 3911-3917

  Choi, Taewoong ^a   Ferris, Stephen T ^a   Matsumoto, Naoki ^b   Poursine Laurent, Jennifer ^a   Yokoyama, Wayne M ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c Division of Rheumatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CONTROLLED STUDY; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MOLECULAR INTERACTION; MOUSE; NATURAL KILLER CELL LICENSING; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BETA 2-MICROGLOBULIN; CELL COMMUNICATION; CYTOTOXICITY, IMMUNOLOGIC; H-2 ANTIGENS; KILLER CELLS, NATURAL; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C;

EID: 79955017552     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1004168     Document Type: Article

References (31)

1. Yokoyama, W. M. 2008. Natural killer cells. In Fundamental Immunology, 6th Ed. W. E. Paul, ed. Lippincott-Raven, New York, p. 483-517.
2. Vivier, E., E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini. 2008. Functions of natural killer cells. Nat. Immunol. 9: 503-510. (Pubitemid 351560519)
3. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274. (Pubitemid 40563170)
4. Ljunggren, H. G., and K. Kärre. 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11: 237-244. (Pubitemid 20198988)
5. Furukawa, H., T. Yabe, K. Watanabe, R. Miyamoto, A. Miki, T. Akaza, K. Tadokoro, S. Tohma, T. Inoue, K. Yamamoto, and T. Juji. 1999. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). Hum. Immunol. 60: 32-40. (Pubitemid 29057854)
6. Liao, N. S., M. Bix, M. Zijlstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science 253: 199-202. (Pubitemid 21917142)
7. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713. (Pubitemid 41117274)
8. Fernandez, N. C., E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423. (Pubitemid 40720789)
9. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342. (Pubitemid 44224147)
10. Kim, S., J. B. Sunwoo, L. Yang, T. Choi, Y. J. Song, A. R. French, A. Vlahiotis, J. F. Piccirillo, M. Cella, M. Colonna, et al. 2008. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl. Acad. Sci. USA 105: 3053-3058. (Pubitemid 351723666)
11. Chalifour, A., L. Scarpellino, J. Back, P. Brodin, E. Devèvre, F. Gros, F. Lévy, G. Leclercq, P. Höglund, F. Beermann, and W. Held. 2009. A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 30: 337-347.
12. Tormo, J., K. Natarajan, D. H. Margulies, and R. A. Mariuzza. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402: 623-631. (Pubitemid 129516325)
13. Matsumoto, N., M. Mitsuki, K. Tajima, W. M. Yokoyama, and K. Yamamoto. 2001. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J. Exp. Med. 193: 147-158.
14. Wang, J., M. C. Whitman, K. Natarajan, J. Tormo, R. A. Mariuzza, and D. H. Margulies. 2002. Binding of the natural killer cell inhibitory receptor Ly49A to its major histocompatibility complex class I ligand. Crucial contacts include both H-2Dd AND beta 2-microglobulin. J. Biol. Chem. 277: 1433-1442. (Pubitemid 34968898)
15. Michaëlsson, J., A. Achour, A. Rö lle, and K. Kärre. 2001. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2- microglobulin subunit. J. Immunol. 166: 7327-7334. (Pubitemid 32525608)
16. Mitsuki, M., N. Matsumoto, and K. Yamamoto. 2004. A species-specific determinant on beta2-microglobulin required for Ly49A recognition of its MHC class I ligand. Int. Immunol. 16: 197-204. (Pubitemid 38195649)
17. Dam, J., R. Guan, K. Natarajan, N. Dimasi, L. K. Chlewicki, D. M. Kranz, P. Schuck, D. H. Margulies, and R. A. Mariuzza. 2003. Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat. Immunol. 4: 1213-1222. (Pubitemid 37540690)
18. Held, W., and R. A. Mariuzza. 2008. Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat. Rev. Immunol. 8: 269-278. (Pubitemid 351432803)
19. Doucey, M. A., L. Scarpellino, J. Zimmer, P. Guillaume, I. F. Luescher, C. Bron, and W. Held. 2004. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat. Immunol. 5: 328-336. (Pubitemid 38332130)
20. Vugmeyster, Y., R. Glas, B. Pérarnau, F. A. Lemonnier, H. Eisen, and H. Ploegh. 1998. Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells. Proc. Natl. Acad. Sci. USA 95: 12492-12497. (Pubitemid 28483792)
21. Bieberich, C., G. Scangos, K. Tanaka, and G. Jay. 1986. Regulated expression of a murine class I gene in transgenic mice. Mol. Cell. Biol. 6: 1339-1342. (Pubitemid 16101563)
22. Khare, S. D., J. Hansen, H. S. Luthra, and C. S. David. 1996. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2- microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J. Clin. Invest. 98: 2746-2755. (Pubitemid 26427401)
23. Pircher, H., T. W. Mak, R. Lang, W. Ballhausen, E. Rü edi, H. Hengartner, R. M. Zinkernagel, and K. Bürki. 1989. T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. EMBO J. 8: 719-727. (Pubitemid 19273242)
24. Gunning, P., J. Leavitt, G. Muscat, S. Y. Ng, and L. Kedes. 1987. A human betaactin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84: 4831-4835. (Pubitemid 17095842)
25. Roland, J., and P. A. Cazenave. 1992. Ly-49 antigen defines an a b TCR population in i-IEL with an extrathymic maturation. Int. Immunol. 4: 699-706.
26. Karlhofer, F. M., R. K. Ribaudo, and W. M. Yokoyama. 1992. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358: 66-70.
27. Kievits, F., P. Ivanyi, P. Krimpenfort, A. Berns, and H. L. Ploegh. 1987. HLArestricted recognition of viral antigens in HLA transgenic mice. Nature 329: 447-449. (Pubitemid 17128315)
28. Jonsson, A. H., L. Yang, S. Kim, S. M. Taffner, and W. M. Yokoyama. 2010. Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J. Immunol. 184: 3424-3432.
29. Franksson, L., J. Sundbäck, A. Achour, J. Bernlind, R. Glas, and K. Kärre. 1999. Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C. Eur. J. Immunol. 29: 2748-2758. (Pubitemid 30098999)
30. Correa, I., and D. H. Raulet. 1995. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2: 61-71.
31. Orihuela, M., D. H. Margulies, and W. M. Yokoyama. 1996. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand. Proc. Natl. Acad. Sci. USA 93: 11792-11797. (Pubitemid 26347202)